Prestige Consumer Healthcare Inc.
PBH US74112D1019
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 68% | 3% | -4% | 26% | -1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Fritz Mary Beth VP |
90.00 USD |
1,678 Sold |
151,020 USD |
10/03/2025 | 10/03/2025 |
| Fritz Mary Beth VP |
85.39 USD |
6,297 Sold |
537,701 USD |
03/03/2025 | 03/03/2025 |
| Mekhail Adel EX VP |
86.30 USD |
5,683 Sold |
490,443 USD |
11/02/2025 | 11/02/2025 |
| Mekhail Adel EX VP |
86.82 USD |
5,400 Sold |
468,828 USD |
11/02/2025 | 11/02/2025 |
| Lombardi Ronald M. CEO |
82.64 USD |
5,662 Sold |
467,908 USD |
19/11/2024 | 19/11/2024 |
| Lombardi Ronald M. CEO |
82.55 USD |
5,213 Sold |
430,333 USD |
19/11/2024 | 19/11/2024 |
| Lombardi Ronald M. CEO |
82.67 USD |
48,512 Sold |
4,010,487 USD |
18/11/2024 | 18/11/2024 |
| Lombardi Ronald M. CEO |
82.67 USD |
48,512 Sold |
4,010,487 USD |
18/11/2024 | 18/11/2024 |
| Lombardi Ronald M. CEO |
82.41 USD |
33,725 Sold |
2,779,277 USD |
18/11/2024 | 18/11/2024 |
| Lombardi Ronald M. CEO |
82.67 USD |
48,512 Sold |
4,010,487 USD |
18/11/2024 | 18/11/2024 |